메뉴 건너뛰기




Volumn 95, Issue 3, 2005, Pages 379-382

Classification of systemic therapies for potential stabilization of the vulnerable plaque to prevent acute myocardial infarction

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; LOSARTAN; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

EID: 12844268242     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.09.037     Document Type: Note
Times cited : (27)

References (48)
  • 1
    • 0027322448 scopus 로고
    • Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease
    • Z.G. Brown, X.Q. Zhao, D.E. Sacco, J.J. Albers Lipid lowering and plaque regression New insights into prevention of plaque disruption and clinical events in coronary disease Circulation 87 1993 1781 1791
    • (1993) Circulation , vol.87 , pp. 1781-1791
    • Brown, Z.G.1    Zhao, X.Q.2    Sacco, D.E.3    Albers, J.J.4
  • 2
    • 0003132710 scopus 로고    scopus 로고
    • Current concepts in cardiovascular pathology: The role of LDL cholesterol in plaque rupture and stabilization
    • P. Libby, U. Schoenbeck, F. Mach, A.P. Selwyn, P. Ganz Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization Am J Med 104 suppl 1998 14S 18S
    • (1998) Am J Med , vol.104 , Issue.SUPPL.
    • Libby, P.1    Schoenbeck, U.2    MacH, F.3    Selwyn, A.P.4    Ganz, P.5
  • 3
    • 0035799341 scopus 로고    scopus 로고
    • Inflammation and thrombosis: The clot thickens
    • P. Libby, D.I. Simon Inflammation and thrombosis: the clot thickens Circulation 103 2001 1718 1720
    • (2001) Circulation , vol.103 , pp. 1718-1720
    • Libby, P.1    Simon, D.I.2
  • 5
    • 0015352648 scopus 로고
    • Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets
    • M.L. Armstrong, M.B. Megan Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets Circ Res 30 1972 675 680
    • (1972) Circ Res , vol.30 , pp. 675-680
    • Armstrong, M.L.1    Megan, M.B.2
  • 6
    • 0032584177 scopus 로고    scopus 로고
    • Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
    • U. Laufs, V. La Fata, J. Plutzky Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
    • (1998) Circulation , vol.97 , pp. 1129-1135
    • Laufs, U.1    La Fata, V.2    Plutzky, J.3
  • 9
    • 0025343047 scopus 로고
    • Effects of captopril on atherosclerosis in cynomolgus monkeys
    • G. Aberg, P. Ferrer Effects of captopril on atherosclerosis in cynomolgus monkeys J Cardiovasc Pharmacol 15 suppl 1990 S65 S72
    • (1990) J Cardiovasc Pharmacol , vol.15 , Issue.SUPPL.
    • Aberg, G.1    Ferrer, P.2
  • 10
    • 0028125199 scopus 로고
    • Antiatherogenic effects of beta-adrenergic blocking agents: Theoretical, experimental, and epidemiologic considerations
    • J.R. Kaplan, S.B. Manuck Antiatherogenic effects of beta-adrenergic blocking agents: theoretical, experimental, and epidemiologic considerations Am Heart J 128 1994 1316 1328
    • (1994) Am Heart J , vol.128 , pp. 1316-1328
    • Kaplan, J.R.1    Manuck, S.B.2
  • 11
    • 0036158710 scopus 로고    scopus 로고
    • Effect of controlled release/extend release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: A 3-year randomized study
    • O. Wiklund, J. Hulthe, J. Wikstrand, C. Schmidt, S.O. Olofsson, G. Bondjers Effect of controlled release/extend release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study Stroke 33 2002 572 577
    • (2002) Stroke , vol.33 , pp. 572-577
    • Wiklund, O.1    Hulthe, J.2    Wikstrand, J.3    Schmidt, C.4    Olofsson, S.O.5    Bondjers, G.6
  • 12
    • 0037015289 scopus 로고    scopus 로고
    • Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice
    • T. Cyrus, S. Sung, L. Zhao, C.D. Funk, S. Tang, D. Pratico Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice Circulation 106 2002 1282 1287
    • (2002) Circulation , vol.106 , pp. 1282-1287
    • Cyrus, T.1    Sung, S.2    Zhao, L.3    Funk, C.D.4    Tang, S.5    Pratico, D.6
  • 13
    • 0030956673 scopus 로고    scopus 로고
    • Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
    • P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
    • (1997) N Engl J Med , vol.336 , pp. 973-979
    • Ridker, P.M.1    Cushman, M.2    Stampfer, M.J.3    Tracy, R.P.4    Hennekens, C.H.5
  • 15
    • 0028267313 scopus 로고
    • Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: The Canadian Coronary Atherosclerosis Intervention Trial
    • D. Waters, L. Higginson, P. Gladstone, B. Kimball, M. Le May, S.J. Boccuzzi, J. Lesperance Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography The Canadian Coronary Atherosclerosis Intervention Trial Circulation 89 1994 959 968
    • (1994) Circulation , vol.89 , pp. 959-968
    • Waters, D.1    Higginson, L.2    Gladstone, P.3    Kimball, B.4    Le May, M.5    Boccuzzi, S.J.6    Lesperance, J.7
  • 17
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
    • (2002) Lancet , vol.360 , pp. 7-22
  • 18
    • 0026786643 scopus 로고
    • Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after MI: Results of the survival and ventricular enlargement trial
    • M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after MI Results of the survival and ventricular enlargement trial N Engl J Med 327 1992 669 677
    • (1992) N Engl J Med , vol.327 , pp. 669-677
    • Pfeffer, M.A.1    Braunwald, E.2    Moye, L.A.3    Basta, L.4    Brown Jr., E.J.5    Cuddy, T.E.6    Davis, B.R.7    Geltman, E.M.8    Goldman, S.9    Flaker, G.C.10
  • 19
    • 0010838455 scopus 로고    scopus 로고
    • Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients: ACE-Inhibitor MI Collaborative Group
    • M.D. Flather, S. Yusuf, L. Kober, M. Pfeffer, A. Hall, G. Murray, C. Torp-Pedersen, S. Ball, J. Pogue, L. Moye, E. Braunwald Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients ACE-Inhibitor MI Collaborative Group Lancet 355 2000 1575 1581
    • (2000) Lancet , vol.355 , pp. 1575-1581
    • Flather, M.D.1    Yusuf, S.2    Kober, L.3    Pfeffer, M.4    Hall, A.5    Murray, G.6    Torp-Pedersen, C.7    Ball, S.8    Pogue, J.9    Moye, L.10    Braunwald, E.11
  • 20
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
    • S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3    Bosch, J.4    Davies, R.5    Dagenais, G.6
  • 21
    • 0027371696 scopus 로고
    • Effects of beta-blockers and calcium channel blockers in acute myocardial infarction
    • P.H. Held, S. Yusuf Effects of beta-blockers and calcium channel blockers in acute myocardial infarction Eur Heart J 14 1993 18 25
    • (1993) Eur Heart J , vol.14 , pp. 18-25
    • Held, P.H.1    Yusuf, S.2
  • 22
    • 0024406369 scopus 로고
    • Final report on the aspirin component of the ongoing Physicians' Health Study
    • Steering Committee of the Physicians' Health Study Research Group
    • Steering Committee of the Physicians' Health Study Research Group Final report on the aspirin component of the ongoing Physicians' Health Study N Engl J Med 321 1989 129 135
    • (1989) N Engl J Med , vol.321 , pp. 129-135
  • 23
    • 0026485080 scopus 로고
    • Double-blind trial of aspirin in primary prevention of MI in patients with stable chronic angina pectoris: The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group
    • S. Juul-Moller, N. Edvardsson, B. Jahnmatz, A. Rosen, S. Sorensen, R. Omblus Double-blind trial of aspirin in primary prevention of MI in patients with stable chronic angina pectoris The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group Lancet 340 1992 1421 1425
    • (1992) Lancet , vol.340 , pp. 1421-1425
    • Juul-Moller, S.1    Edvardsson, N.2    Jahnmatz, B.3    Rosen, A.4    Sorensen, S.5    Omblus, R.6
  • 25
    • 0037024326 scopus 로고    scopus 로고
    • Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: A randomized, double-blind, placebo-controlled trial
    • P. Wiesli, W. Czerwenka, A. Meniconi, F.E. Maly, U. Hoffmann, W. Vetter, G. Schulthess Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial Circulation 105 2002 2646 2652
    • (2002) Circulation , vol.105 , pp. 2646-2652
    • Wiesli, P.1    Czerwenka, W.2    Meniconi, A.3    Maly, F.E.4    Hoffmann, U.5    Vetter, W.6    Schulthess, G.7
  • 27
    • 0033514107 scopus 로고    scopus 로고
    • Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association
    • AHA Science Advisory D.C.
    • D.C. Tribble AHA Science Advisory Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and beta-carotene: a statement for healthcare professionals from the American Heart Association Circulation 99 1999 591 595
    • (1999) Circulation , vol.99 , pp. 591-595
    • Tribble1
  • 28
    • 0036140785 scopus 로고    scopus 로고
    • Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering
    • S.N. Doshi, I.F. McDowell, S.J. Moat, N. Payne, H.J. Durrant, M.J. Lewis, J. Goodfellow Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering Circulation 105 2002 22 26
    • (2002) Circulation , vol.105 , pp. 22-26
    • Doshi, S.N.1    McDowell, I.F.2    Moat, S.J.3    Payne, N.4    Durrant, H.J.5    Lewis, M.J.6    Goodfellow, J.7
  • 29
    • 0036623832 scopus 로고    scopus 로고
    • Clinical trials update: Highlights of the scientific sessions of the American College of Cardiology 2002
    • Coletta A, Thackray S, Nikitin N, Cleland JG. Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002. Eur J Heart Fail 2002:381-388.
    • (2002) Eur J Heart Fail , pp. 381-388
    • Coletta, A.1    Thackray, S.2    Nikitin, N.3    Cleland, J.G.4
  • 30
    • 0035203840 scopus 로고    scopus 로고
    • Antioxidants and atherosclerotic cardiovascular disease: Unresolved issues
    • D.C. Tribble Antioxidants and atherosclerotic cardiovascular disease: unresolved issues Coron Artery Dis 7 2001 541 546
    • (2001) Coron Artery Dis , vol.7 , pp. 541-546
    • Tribble, D.C.1
  • 32
    • 0037160969 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
    • LIFE Study Group K.
    • L.H. Lindholm, H. Ibsen, B. Dahlof, R.B. Devereux, G. Beevers, U. de Faire, F. Fyhrquist, S. Julius, S.E. Kjeldsen, K. Kristiansson LIFE Study Group Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 1004 1010
    • (2002) Lancet , vol.359 , pp. 1004-1010
    • Lindholm, L.H.1    Ibsen, H.2    Dahlof, B.3    Devereux, R.B.4    Beevers, G.5    De Faire, U.6    Fyhrquist, F.7    Julius, S.8    Kjeldsen, S.E.9    Kristiansson10
  • 33
    • 0037137299 scopus 로고    scopus 로고
    • Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
    • P.M. Kris-Etherton, W.S. Harris, L.J. Appel Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 2002 2747 2757
    • (2002) Circulation , vol.106 , pp. 2747-2757
    • Kris-Etherton, P.M.1    Harris, W.S.2    Appel, L.J.3
  • 35
    • 0035698468 scopus 로고    scopus 로고
    • The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: Heart and brain
    • A. Leaf The electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of n-3 polyunsaturated fatty acids: heart and brain Lipids 36 2001 S107 S110
    • (2001) Lipids , vol.36
    • Leaf, A.1
  • 36
    • 0036124659 scopus 로고    scopus 로고
    • N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials
    • H.C. Bucher, P. Hengstler, C. Schindler, G. Meier N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials Am J Med 112 2002 298 304
    • (2002) Am J Med , vol.112 , pp. 298-304
    • Bucher, H.C.1    Hengstler, P.2    Schindler, C.3    Meier, G.4
  • 37
    • 0025347391 scopus 로고
    • Blood pressure, stroke, and coronary heart disease: Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
    • R. Collins, R. Peto, S. MacMahon, P. Hebert, N.H. Fiebach, K.A. Eberlein, J. Godwin, N. Qizilbash, J.O. Taylor, C.H. Hennekens Blood pressure, stroke, and coronary heart disease Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 335 1990 827 838
    • (1990) Lancet , vol.335 , pp. 827-838
    • Collins, R.1    Peto, R.2    MacMahon, S.3    Hebert, P.4    Fiebach, N.H.5    Eberlein, K.A.6    Godwin, J.7    Qizilbash, N.8    Taylor, J.O.9    Hennekens, C.H.10
  • 38
    • 0002266162 scopus 로고
    • Antihypertensive drug therapy: Effects on stroke and coronary heart disease
    • J.D. Swales Blackwell Scientific Publications Oxford
    • R. Collins, R. Peto Antihypertensive drug therapy: effects on stroke and coronary heart disease J.D. Swales Textbook of Hypertension 1994 Blackwell Scientific Publications Oxford 1156 1164
    • (1994) Textbook of Hypertension , pp. 1156-1164
    • Collins, R.1    Peto, R.2
  • 39
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • The ALLHAT Research Group
    • The ALLHAT Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
    • (2002) JAMA , vol.288 , pp. 2981-2997
  • 40
    • 0037047092 scopus 로고    scopus 로고
    • Cyclooxygenase-2 inhibition and cardiovascular events
    • B. Pitt, C. Pepine, J.T. Willerson Cyclooxygenase-2 inhibition and cardiovascular events Circulation 106 2002 167 169
    • (2002) Circulation , vol.106 , pp. 167-169
    • Pitt, B.1    Pepine, C.2    Willerson, J.T.3
  • 41
    • 0031744030 scopus 로고    scopus 로고
    • Role of inflammation and metalloproteinases in plaque disruption and thrombosis
    • P.K. Shah Role of inflammation and metalloproteinases in plaque disruption and thrombosis Vasc Med 3 1998 199 206
    • (1998) Vasc Med , vol.3 , pp. 199-206
    • Shah, P.K.1
  • 42
    • 0037432146 scopus 로고    scopus 로고
    • Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice
    • P. Naghavi, S. Wyde, M. Litovsky Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice Circulation 107 2003 762 768
    • (2003) Circulation , vol.107 , pp. 762-768
    • Naghavi, P.1    Wyde, S.2    Litovsky, M.3
  • 43
    • 0037035475 scopus 로고    scopus 로고
    • Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: The FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study
    • E.P. Gurfinkel, L. de la Fuente, O. Mendiz, B. Mautner Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study Circulation 105 2002 2143 2147
    • (2002) Circulation , vol.105 , pp. 2143-2147
    • Gurfinkel, E.P.1    De La Fuente, L.2    Mendiz, O.3    Mautner, B.4
  • 44
    • 0030590746 scopus 로고    scopus 로고
    • A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
    • CAPRIE Steering Committee
    • CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
    • (1996) Lancet , vol.348 , pp. 1329-1339
  • 45
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators
    • The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
    • (2001) N Engl J Med , vol.345 , pp. 494-502
  • 47
    • 0033864582 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
    • A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J Clin Invest 106 2000 523 531
    • (2000) J Clin Invest , vol.106 , pp. 523-531
    • Li, A.C.1    Brown, K.K.2    Silvestre, M.J.3    Willson, T.M.4    Palinski, W.5    Glass, C.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.